Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRNX

Crinetics Pharmaceuticals (CRNX)

Crinetics Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CRNX
DateTimeSourceHeadlineSymbolCompany
03/11/20244:15PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20248:18PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20248:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20248:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20248:00PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20247:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/06/20247:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
03/01/20244:41PMEdgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CRNXCrinetics Pharmaceuticals Inc
02/28/20244:09PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
02/14/20244:28PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
02/12/20244:32PMEdgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/26/20245:50PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/25/20241:03PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/12/20244:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/10/202412:10PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/08/20248:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/04/20244:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/04/20244:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/03/20244:11PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
01/02/20244:44PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/27/20235:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/26/202311:47AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/22/20236:45PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/21/20235:28PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/18/20234:12PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/13/20234:44PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/12/20234:35PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRNXCrinetics Pharmaceuticals Inc
12/11/20231:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/29/20234:31PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
11/27/202311:40AMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:CRNXCrinetics Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CRNX